Recent targeted therapies are focusing on molecular pathways implicated in OA progression, including TGF-/ALK5 signaling, Wnt/-catenin modulation, NF-B suppression, and ferroptosis inhibition (Tian et al., 2025
Although Ozempic, Trulicity, and other GLP-1 drugs have long been used for type 2 diabetes management, the approval of specific GLP-1 agonists for weight loss purposes in the United States has put them back in the spotlight
Product colour may differ in person due to screen settings and natural variation in active ingredients
Non-alcoholic fatty liver disease (NAFLD) is primarily associated with metabolic factors such as obesity, type 2 diabetes, and dyslipidaemia
Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed